Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress

Andrea M Vincent1, Lorena Perrone, Kelli A Sullivan

  • 1Department of Neurology, Room 5017 BSRB, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, Michigan 48109, USA. andreav@umich.edu

Endocrinology
|November 11, 2006
PubMed

Insights

The receptor for advanced glycation end products (RAGE) is present in nerve cells and contributes to diabetic neuropathy by increasing oxidative stress. Therapies targeting RAGE or oxidative stress may prevent nerve damage in diabetes.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Molecular Biology

Background:

  • The receptor for advanced glycation end products (RAGE) is implicated in diabetic vascular and renal complications via oxidative stress pathways.
  • Limited research exists on RAGE expression and its role in diabetic neuropathy, a common complication of diabetes.

Purpose of the Study:

  • To investigate the presence and function of RAGE in dorsal root ganglia neurons.
  • To determine if RAGE activation in neurons contributes to oxidative stress and cellular injury relevant to diabetic neuropathy.

Main Methods:

  • Demonstrated functional RAGE expression in dorsal root ganglia neurons.
  • Exposed neurons to the RAGE ligand S100 to assess downstream signaling, oxidative stress, and cellular injury.
  • Evaluated the effect of the antioxidant alpha-lipoic acid on RAGE-mediated events.

Main Results:

  • Dorsal root ganglia neurons express functional RAGE and exhibit downstream signaling, oxidative stress, and cellular injury upon S100 stimulation.
  • RAGE activation led to increased reactive oxygen species, caspase-3 activation, and DNA degradation.
  • Alpha-lipoic acid treatment effectively prevented these RAGE-induced cellular damages.

Conclusions:

  • RAGE signaling in neurons contributes to oxidative stress and cellular injury, suggesting a role in diabetic neuropathy development.
  • Therapeutic strategies targeting RAGE ligands, RAGE signaling blockade, or oxidative stress prevention show promise for treating diabetic neuropathy.

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...